These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 8262843)
41. Accelerated superfractionated radiotherapy with concomitant boost for locally advanced head-and-neck squamous cell carcinomas. Morris MM; Schmidt-Ullrich RK; DiNardo L; Manning MA; Silverman L; Clay L; Johnson CR; Amir C Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):918-28. PubMed ID: 11958884 [TBL] [Abstract][Full Text] [Related]
42. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck. Høyer M; Jørgensen K; Bundgaard T; Johansen LV; Bentzen SM; Overgaard M; Hansen O; Søgaard H; Overgaard J Radiother Oncol; 1998 Feb; 46(2):147-55. PubMed ID: 9510042 [TBL] [Abstract][Full Text] [Related]
43. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India. Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310 [TBL] [Abstract][Full Text] [Related]
44. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Allal AS; Maire D; Becker M; Dulguerov P Cancer; 2000 Feb; 88(3):648-52. PubMed ID: 10649260 [TBL] [Abstract][Full Text] [Related]
46. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer. Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881 [TBL] [Abstract][Full Text] [Related]
47. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas]. Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270 [TBL] [Abstract][Full Text] [Related]
48. Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. Johnson CR; Schmidt-Ullrich RK; Wazer DE Cancer; 1992 Jun; 69(11):2749-54. PubMed ID: 1571905 [TBL] [Abstract][Full Text] [Related]
49. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma. Dirix P; Nuyts S Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402 [TBL] [Abstract][Full Text] [Related]
50. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule. Numico G; Russi EG; Vitiello R; Sorrentino R; Colantonio I; Cipolat M; Taglianti RV; Pelissero A; Fea E; Granetto C; Di Costanzo G; Gasco M; Garrone O; Occelli M; Merlano M Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):731-7. PubMed ID: 17011449 [TBL] [Abstract][Full Text] [Related]
51. Role of concomitant chemoradiation in locally advanced head and neck cancers. Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629 [TBL] [Abstract][Full Text] [Related]
56. [Accelerated radiotherapy with the concomitant-boost technic in patients with squamous cell carcinoma of the head and neck]. Sanguineti G; Corvò R; Frascio F; Vitale V Radiol Med; 1994 Nov; 88(5):650-6. PubMed ID: 7824783 [TBL] [Abstract][Full Text] [Related]
57. Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot? Haustermans K; Fowler J; Geboes K; Christiaens MR; Lerut A; van der Schueren E Radiother Oncol; 1998 Feb; 46(2):157-67. PubMed ID: 9510043 [TBL] [Abstract][Full Text] [Related]
58. Preoperative irradiation in cancer of the head and neck. Moore C; Mullins F; Scott RM Am J Surg; 1972 Oct; 124(4):555-8. PubMed ID: 4627680 [No Abstract] [Full Text] [Related]
59. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):137-48. PubMed ID: 9300748 [TBL] [Abstract][Full Text] [Related]
60. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck. MacKenzie R; Balogh J; Choo R; Franssen E Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]